Vollum Institute, Oregon Health & Science University, Portland, OR, USA.
Department of Biochemistry, NIH Center for Macromolecular Modeling and Bioinformatics, Center for Biophysics and Quantitative Biology, and Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Nature. 2019 May;569(7754):141-145. doi: 10.1038/s41586-019-1135-1. Epub 2019 Apr 24.
The serotonin transporter (SERT) regulates neurotransmitter homeostasis through the sodium- and chloride-dependent recycling of serotonin into presynaptic neurons. Major depression and anxiety disorders are treated using selective serotonin reuptake inhibitors-small molecules that competitively block substrate binding and thereby prolong neurotransmitter action. The dopamine and noradrenaline transporters, together with SERT, are members of the neurotransmitter sodium symporter (NSS) family. The transport activities of NSSs can be inhibited or modulated by cocaine and amphetamines, and genetic variants of NSSs are associated with several neuropsychiatric disorders including attention deficit hyperactivity disorder, autism and bipolar disorder. Studies of bacterial NSS homologues-including LeuT-have shown how their transmembrane helices (TMs) undergo conformational changes during the transport cycle, exposing a central binding site to either side of the membrane. However, the conformational changes associated with transport in NSSs remain unknown. To elucidate structure-based mechanisms for transport in SERT we investigated its complexes with ibogaine, a hallucinogenic natural product with psychoactive and anti-addictive properties. Notably, ibogaine is a non-competitive inhibitor of transport but displays competitive binding towards selective serotonin reuptake inhibitors. Here we report cryo-electron microscopy structures of SERT-ibogaine complexes captured in outward-open, occluded and inward-open conformations. Ibogaine binds to the central binding site, and closure of the extracellular gate largely involves movements of TMs 1b and 6a. Opening of the intracellular gate involves a hinge-like movement of TM1a and the partial unwinding of TM5, which together create a permeation pathway that enables substrate and ion diffusion to the cytoplasm. These structures define the structural rearrangements that occur from the outward-open to inward-open conformations, and provide insight into the mechanism of neurotransmitter transport and ibogaine inhibition.
血清素转运体(SERT)通过钠依赖和氯依赖的将血清素再循环到突触前神经元来调节神经递质的稳态。使用选择性 5-羟色胺再摄取抑制剂(可竞争性阻断底物结合从而延长神经递质作用的小分子)来治疗重度抑郁症和焦虑症。多巴胺和去甲肾上腺素转运体与 SERT 一起是神经递质钠协同转运体(NSS)家族的成员。NSS 的转运活性可被可卡因和安非他命抑制或调节,并且 NSS 的遗传变异与包括注意缺陷多动障碍、自闭症和双相情感障碍在内的多种神经精神疾病有关。对包括 LeuT 在内的细菌 NSS 同源物的研究表明,它们的跨膜螺旋(TMs)在转运周期中如何发生构象变化,从而在膜的两侧暴露中央结合位点。然而,与 NSS 转运相关的构象变化仍不清楚。为了阐明 SERT 转运的基于结构的机制,我们研究了它与伊博加因的复合物,伊博加因是一种具有致幻和抗成瘾特性的天然产物。值得注意的是,伊博加因是非竞争性转运抑制剂,但对选择性 5-羟色胺再摄取抑制剂显示出竞争性结合。在这里,我们报告了 SERT-伊博加因复合物在向外开放、阻塞和向内开放构象下的冷冻电镜结构。伊博加因结合到中央结合位点,而细胞外门的关闭主要涉及 TMs 1b 和 6a 的运动。细胞内门的打开涉及 TM1a 的铰链样运动和 TM5 的部分解旋,它们共同形成允许底物和离子扩散到细胞质的渗透途径。这些结构定义了从外向开放到内向开放构象发生的结构重排,并为神经递质转运和伊博加因抑制的机制提供了深入的了解。